AIMD - Ainos, Inc. Price to Earnings Adjusted for Growth Rate

Corporate company logo of Ainos Corporation (AIMD)

Ainos, Inc. is optimizing test production through contract manufacturing sites and cloud IT outsourcing. The valuation-to-growth ratio reflects market expectations, with the indicator reaching 0.00. Meanwhile, the company adheres to bioethics and environmental standards. However, dependence on regulators and fierce competition in the AI diagnostics sector create risks for customer retention.

Ainos Corp (AIMD): PEG Multiple from 04/28/2023 to 11/12/2026
Core merchandise of Ainos, Inc.

The PEG ratio compares the market value of earnings to their future growth rates, identifying undervalued assets when the value falls below one. This metric allows for an assessment of whether current capitalization is justified by the business's growth dynamics. By analyzing the current P/E-to-growth ratio, an investor can see the balance between price and expansion potential. For Ainos, Inc. (AIMD), this indicator is critical due to a lack of pricing power. Dependence on the terms of major distributors makes future earnings forecasts extremely volatile.

Competitors of Ainos, Inc.

Price/Earnings to Growth Ratio A (Agilent Technologies, Inc.)|Quest - Price/Earnings to Growth Multiple|Illumina Platform (ILMN) - Price to Earnings Adjusted for Growth Rate|EXAS - Price/Earnings to Growth Ratio|Growth-Adjusted Market Cap to Net Income revvity.com RVTY|BIO: PEG Multiple|NNNN - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Sterigenics|QuidelOrtho Inc. (QDEL) - Growth-Adjusted Market Cap to Net Income|PEG Multiple OPK|PEG Multiple CareDx, Inc. (CDNA)|PEG Multiple MRVI (Maravai LifeSciences Holdings, Inc.)|Growth-Adjusted Market Cap to Net Income Fulgent Genetics Inc (FLGT)|LAB - Price/Earnings to Growth Ratio|CTKB (Cytek Corp) - Growth-Adjusted P/E Ratio|OraSure Technologies (OSUR) - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate Exagen (XGN)|Price/Earnings to Growth Ratio MDxHealth|Lucid Diagnostics, Inc. (LUCD) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple PRE (Prenetics Global)|IMDX (imdxinc.com) - Growth-Adjusted Payback Ratio|PEG Multiple TRIB (Trinity Biotech)|Growth-Adjusted Market Cap to Net Income prophaselabs.com (PRPH)|CODX - Price/Earnings to Growth Ratio|HSCS (Heart Test Laboratories, Inc.) - Growth-Adjusted P/E Ratio|BMRA: PEG Multiple|Price/Earnings to Growth Multiple Cardio Diagnostics Holdings|Price/Earnings to Growth Multiple ONCO|viraxbiolabs.com (VRAX) - Growth-Adjusted Market Cap to Net Income|PEG Multiple BJDX|PEG Multiple Aspira Women's Health, Inc. (AWH)|PEG Multiple AXDX (Accelerate Diagnostics, Inc)|Growth-Adjusted Market Cap to Net Income Centogene NV (CNTG)|ENZ - Price/Earnings to Growth Ratio|Fresh2 Group Limited (FRES) - Price/Earnings to Growth Multiple|GENE: PEG Multiple|Growth-Adjusted P/E Ratio ME|Price/Earnings to Growth Ratio Psychemedics Corp